{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:03:58Z","timestamp":1781071438025,"version":"3.54.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Olfactomedin-like protein 3 (OLFML3) is a secreted glycoprotein that is primarily deemed to be associated with embryonic development, angiogenesis, and tumorigenesis. Recent studies have highlighted the function of OLFML3 as an important regulatory protein in viral and bacterial infections. This study explores the role of OLFML3 in type I interferon (IFN-I) signaling in RNA virus infection and related mechanism of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      RT-qPCR was used to determine the effects of OLFML3 on IFN-I production in the RNA virus infection.\n                      <jats:italic>Olfml3<\/jats:italic>\n                      <jats:sup>-\/-<\/jats:sup>\n                      mice was used to evaluate the effects of OLFML3 in in vivo viral infection. Western blotting (WB) and immunofluorescence microscropy experiments were conducted to analyze the effects of OLFML3 on retinoic-acid-inducible gene I (RIGI)-mediated IFN-I signaling pathway. Mass spectrometry and co-immunoprecipitation (Co-IP) were used to analyze the partner proteins of OLFML3. Gain-of-function studies by overexpression and loss-of-function studies by gene knockout and knockdown were performed to understand the functions of OLFML3 and TRIM21 in RIG-I-mediated IFN-I signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>OLFML3 can inhibit IFN-I production in RNA virus infection by suppressing RIG-I signaling. OLFML3 interacts with the PRY\/SPRY domain of TRIM21, an E3 ubiquitinligase. OLFML3 can disrupt TRIM21-mediated RIG-I K63-ubiquitination, leading to the destabilization of RIG-I and suppressed IFN-I signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OLFML3 functions as a general immunosuppressor in RNA virus infection. These results may help developing OLFML3-targeted antiviral therapeutics for the re-activation of IFN-I signaling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1810852","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:39:59Z","timestamp":1781069999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["OLFML3 negatively regulates RIG-I signaling in RNA virus infection"],"prefix":"10.3389","volume":"17","author":[{"given":"Qian","family":"Gu","sequence":"first","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Mei","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]},{"name":"Guangzhou Laboratory","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Hu","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]},{"name":"Guangzhou Laboratory","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieming","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University","place":["Shanghai, China"]},{"name":"Guangzhou Laboratory","place":["Guangzhou, Guangdong, China"]},{"name":"Shanghai Clinical Research and Trial Center","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.febslet.2004.06.059","article-title":"hOLF44, a secreted glycoprotein with distinct expression pattern, belongs to an uncharacterized olfactomedin-like subfamily newly identified by phylogenetic analysis","volume":"571","author":"Zeng","year":"2004","journal-title":"FEBS Lett"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2014.00006","article-title":"Olfactomedin proteins: central players in development and disease","volume":"2","author":"Anholt","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000000309","article-title":"Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis","volume":"132","author":"Jin","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.3821","article-title":"OLFML3 expression is decreased during prenatal muscle development and regulated by microRNA-155 in pigs","volume":"8","author":"Zhao","year":"2012","journal-title":"Int J Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2024.01.008","article-title":"OLFML3 suppresses trophoblast apoptosis via the PI3K\/AKT pathway: A possible therapeutic target in preeclampsia","volume":"147","author":"Chen","year":"2024","journal-title":"Placenta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.3390\/cancers13184625","article-title":"Targeting OLFML3 in colorectal cancer suppresses tumor growth and angiogenesis, and increases the efficacy of anti-PD1 based immunotherapy","volume":"13","author":"Stalin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.008","article-title":"Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation","volume":"134","author":"Inomata","year":"2008","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-12-0245","article-title":"Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage","volume":"11","author":"Miljkovic-Licina","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000751rr","article-title":"Olfactomedin-like 3 promotes PDGF-dependent pericyte proliferation and migration during embryonic blood vessel formation","volume":"34","author":"Imhof","year":"2020","journal-title":"FASEB J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.3390\/ijms232314613","article-title":"Microglia-derived olfactomedin-like 3 is a potent angiogenic factor in primary mouse brain endothelial cells: A novel target for glioblastoma","volume":"23","author":"Joseph","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/wrr.12485","article-title":"Biodegradable and plasma-treated electrospun scaffolds coated with recombinant olfactomedin-like 3 for accelerating wound healing and tissue regeneration","volume":"24","author":"Dunn","year":"2016","journal-title":"Wound Repair Regener"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578411","article-title":"Co-localization and co-expression of Olfml3 with Iba1 in brain of mice","volume":"394","author":"Yadav","year":"2024","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01728","article-title":"Microglia-specific expression of Olfml3 is directly regulated by transforming growth factor beta1-induced smad2 signaling","volume":"9","author":"Neidert","year":"2018","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0400","article-title":"Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Cancer Discov"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13052","DOI":"10.3390\/ijms222313052","article-title":"Microglia-derived olfactomedin-like 3 promotes pro-tumorigenic microglial function and Malignant features of glioma cells","volume":"22","author":"Toedebusch","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-21-0559","article-title":"Circadian regulator CLOCK drives immunosuppression in glioblastoma","volume":"10","author":"Xuan","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112127","article-title":"Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma","volume":"42","author":"Pang","year":"2023","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/jci178628","article-title":"Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma","volume":"134","author":"Liu","year":"2024","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12951-023-01801-w","article-title":"Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling","volume":"21","author":"Liu","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2023.10.005","article-title":"miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A","volume":"8","author":"Song","year":"2023","journal-title":"NCRNA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13059-021-02513-w","article-title":"Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist (vol 22, 297, 2021)","volume":"22","author":"Mei","year":"2021","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.103859","article-title":"OLFML3 promotes IRG1 mitochondrial localization and modulates mitochondrial function in macrophages","volume":"21","author":"Yu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.110","article-title":"The propagation, quantification, and storage of vesicular stomatitis virus","volume":"58","author":"Abdelmageed","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.10.013","article-title":"From periphery to center stage: 50 years of advancements in innate immunity","volume":"187","author":"Carpenter","year":"2024","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100781","article-title":"Luciferase reporter assays to monitor interferon signaling modulation by SARS-CoV-2 proteins","volume":"2","author":"Hirschenberger","year":"2021","journal-title":"STAR Protoc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg2339","article-title":"VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation","volume":"9","author":"Hu","year":"2023","journal-title":"Sci Adv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202301142","article-title":"A interacting model: How TRIM21 orchestrates with proteins in intracellular immunity","volume":"28","author":"Huang","year":"2023","journal-title":"Small Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3390\/ijms24021683","article-title":"Multiple roles of TRIM21 in virus infection","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00321-18","article-title":"TRIM21 promotes innate immune response to RNA viral infection through Lys27-linked polyubiquitination of MAVS","volume":"92","author":"Xue","year":"2018","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - Roles in innate immunity and autoimmune disease","volume":"12","author":"Jones","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112272","article-title":"UBL7 enhances antiviral innate immunity by promoting Lys27-linked polyubiquitination of MAVS","volume":"42","author":"Jiang","year":"2023","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112002","article-title":"Type I interferon\/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner","volume":"42","author":"Kong","year":"2023","journal-title":"Cell Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011776","article-title":"Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors","volume":"5","author":"Higgs","year":"2010","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2492","article-title":"The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA","volume":"14","author":"Zhang","year":"2013","journal-title":"Nat Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310892","article-title":"TRIM21 promotes rabies virus production by degrading IRF7 through ubiquitination","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.01.047","article-title":"Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy","volume":"33","author":"Shi","year":"2025","journal-title":"Mol Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.03.015","article-title":"TRIM21 ubiquitylates SQSTM1\/p62 and suppresses protein sequestration to regulate redox homeostasis","volume":"61","author":"Pan","year":"2016","journal-title":"Mol Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2519063","article-title":"Macrophage TRIM21 knockout inhibits septic acute lung injury by downregulating autophagy regulator protein ubiquitination","volume":"21","author":"Xie","year":"2025","journal-title":"Autophagy"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2024.2394308","article-title":"TRIM21-mediated ubiquitination of SQSTM1\/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity","volume":"21","author":"Yang","year":"2025","journal-title":"Autophagy"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2164427","article-title":"Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules","volume":"19","author":"Yang","year":"2023","journal-title":"Autophagy"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.02.002","article-title":"Dynamic control of type I IFN signalling by an integrated network of negative regulators","volume":"36","author":"Porritt","year":"2015","journal-title":"Trends Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2013.04.002","article-title":"Fine tuning type I interferon responses","volume":"24","author":"Hertzog","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001269107","article-title":"Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection","volume":"107","author":"Liu","year":"2010","journal-title":"PNAS"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1172\/jci68453","article-title":"Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease","volume":"123","author":"Liu","year":"2013","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s335915","article-title":"OLFM4 regulates lung epithelial cell function in sepsis-associated ARDS\/ALI via LDHA-mediated NF-\u03baB signaling","volume":"14","author":"Gong","year":"2021","journal-title":"J Inflammation Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02160-10","article-title":"Adenovirus virus-associated RNAs induce type I interferon expression through a RIG-I-mediated pathway","volume":"85","author":"Minamitani","year":"2011","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009823107","article-title":"Induction of type I interferon by adenovirus-encoded small RNAs","volume":"107","author":"Yamaguchi","year":"2010","journal-title":"PNSA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.04.002","article-title":"The RNA polymerase III-RIG-I axis in antiviral immunity and inflammation","volume":"44","author":"Naesens","year":"2023","journal-title":"Trends Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:40:00Z","timestamp":1781070000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2026.1810852"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1810852","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1810852"}}